Credit Suisse Raises CVS Health's Price Target to $125 From $117, Keeps Outperform Rating
© MT Newswires 2022
All news about CVS HEALTH CORPORATION |
|
|
|
Analyst Recommendations on CVS HEALTH CORPORATION |
|
|
| |
|
Sales 2022 |
315 B
-
-
|
Net income 2022 |
4 370 M
-
-
|
Net Debt 2022 |
39 275 M
-
-
|
P/E ratio 2022 |
28,8x |
Yield 2022 |
2,53% |
|
Capitalization |
113 B
113 B
-
|
EV / Sales 2022 |
0,48x |
EV / Sales 2023 |
0,46x |
Nbr of Employees |
258 000 |
Free-Float |
74,5% |
|
Chart CVS HEALTH CORPORATION |
|
Duration :
Period :
|
 |
|
Technical analysis trends CVS HEALTH CORPORATION
| Short Term | Mid-Term | Long Term | Trends | Bearish | Bearish | Bearish |
Income Statement Evolution
|
Mean consensus |
OUTPERFORM |
Number of Analysts |
27 |
Last Close Price |
86,18 $ |
Average target price |
115,86 $ |
Spread / Average Target |
34,4% |
|